SCHEMBL15528285

SCHEMBL15528285

O=c1c(-c2cccc(F)c2)c(CCO)oc2ccc(F)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 9/20 0.51
GABRD O14764 9/20 0.51
GABRA1 P14867 9/20 0.51
GABRB1 P18505 9/20 0.51
GABRG2 P18507 9/20 0.51
GABRB3 P28472 9/20 0.51
GABRA5 P31644 9/20 0.51
GABRA3 P34903 9/20 0.51
GABRA2 P47869 9/20 0.51
GABRB2 P47870 9/20 0.51
GABRA4 P48169 9/20 0.51
GABRE P78334 9/20 0.51
GABRA6 Q16445 9/20 0.51
GABRG1 Q8N1C3 9/20 0.51
GABRG3 Q99928 9/20 0.51
GABRQ Q9UN88 9/20 0.51
TNKS O95271 1/20 0.43
NQO1 P15559 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15528008 0.91 GABRP (0.50) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL15528315 0.91 TNKS (0.50) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8932 0.87 GABRP (0.51) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL9273 0.84 GABRP (0.53) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8856 0.84 GABRA1 (0.53) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL15528119 0.84 GABRP (0.48) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL13726082 0.84 AR (0.40) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8632 0.80 GABRP (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL15528004 0.79 GABRP (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8108 0.79 GABRP (0.50) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2844647-A1 PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2- (1 -HYDROXY- ALKYL) - CHROMEN - 4 - ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS Rhizen Pharmaceuticals S.A. (CH) 2015-03-11 EP claimed
WO-2013164801-A1 PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2- (1 -HYDROXY- ALKYL) - CHROMEN - 4 - ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS RHIZEN PHARMACEUTICALS SA (CH) 2013-11-07 WO claimed
EP-2870157-A1 SELECTIVE PI3K DELTA INHIBITORS Rhizen Pharmaceuticals S.A. (CH) 2015-05-13 EP disclosed
EP-2844647-A1 PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2- (1 -HYDROXY- ALKYL) - CHROMEN - 4 - ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS Rhizen Pharmaceuticals S.A. (CH) 2015-03-11 EP disclosed
WO-2014006572-A1 SELECTIVE PI3K DELTA INHIBITORS RHIZEN PHARMACEUTICALS SA (CH) 2014-01-09 WO disclosed
WO-2013164801-A1 PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2- (1 -HYDROXY- ALKYL) - CHROMEN - 4 - ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS RHIZEN PHARMACEUTICALS SA (CH) 2013-11-07 WO disclosed